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The heme dioxygenase enzymes catalyze the ﬁrst and rate-limiting step in the kynurenine pathway, the O2-dependent
oxidation of L-tryptophan to N-formylkynurenine. This reaction
is unique in heme chemistry. Somewhat confusingly, this enzyme
in the early literature is termed “tryptophan pyrrolase”13 (and
even “tryptophan peroxidase-oxidase”4); only later did the
nomenclature converge on either tryptophan 2,3-dioxygenase
(TDO) or indoleamine 2,3-dioxygenase (IDO). Actually, both
TDO and IDO catalyze the same reaction (Scheme 1), with the
diﬀerent denominations merely reﬂecting the generally wider
substrate speciﬁcity of the IDOs compared to themore substrate-
speciﬁc TDOs.
The ﬁrst report of a heme dioxygenase enzyme came more
than 70 years ago,1 but the vast majority of the spectroscopic and
kinetic studies were conducted in the 1970s and 1980s. In 1996,
an informative summary of this early dioxygenase literature was
published5 as part of a larger review of heme-containing oxyge-
nases. At that time, recombinant expression systems for dioxy-
genases were not widely available and there was no published
structural information. In the past 10 years, there have been
substantial developments, including high-resolution structural
information, new bacterial expression systems, important con-
tributions from computational chemistry, and emerging mechan-
istic data from site-directed mutagenesis, all of which has moved
the ﬁeld forward and has meant that the original mechanistic
proposals have required revision. This review summarizes these
recent contributions. It is not an exhaustive account; instead, this
article focuses speciﬁcally on structural and mechanistic aspects
and attempts to present a concise, comparative summary that is
relevant to those with a broader interest in heme protein
structure and function.
’BACKGROUND
Prior to the publication of structural information (or the
development of recombinant expression systems), there had
been a considerable eﬀort directed toward understanding the
mechanism and reactivity of heme dioxygenases. This has been
reviewed previously,5 and we do not re-rehearse it here. It is,
though, instructive to brieﬂy summarize the main conclusions
that had been drawn from these studies, because they provide
context and a useful framework for the discussion that follows.
A number of diﬀerent indicators had led to the convincing and
well-cited idea that the dioxygenase active site contained a distal
histidine residue that was catalytically important. To start with,
Scheme 1. Reaction Catalyzed by the Heme Dioxygenases
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ABSTRACT: As members of the family of heme-dependent enzymes, the heme
dioxygenases are diﬀerentiated by virtue of their ability to catalyze the oxidation of L-
tryptophan to N-formylkynurenine, the ﬁrst and rate-limiting step in tryptophan
catabolism. In the past several years, there have been a number of important
developments that have meant that established proposals for the reaction mechanism
in the heme dioxygenases have required reassessment. This focused review presents a
summary of these recent advances, written from a structural and mechanistic perspec-
tive. It attempts to present answers to some of the long-standing questions, to highlight
as yet unresolved issues, and to explore the similarities and diﬀerences of other well-
known catalytic heme enzymes such as the cytochromes P450, NO synthase, and
peroxidases.
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the reaction mechanism was known to involve O2 binding to the
heme: this was highly reminiscent of O2 binding to the heme-
containing globins in which hydrogen bonding interactions
between bound O2 and a distal histidine were well documented
6
(the peroxidase enzymes also employ similar hydrogen bonding
interactions710). Reassuringly, there was also sequence homology
with a group of IDO-like myoglobins that were also presumed to
contain a distal histidine (reviewed in ref 11). Further evidence of
a distal histidine residue arose from spectroscopic data (reviewed
in ref 5) that had revealed the presence of a low-spin heme
species under certain conditions. Many of these spectroscopic
features (which were later observed for the recombinant pro-
teins, too12,13) were similar to those found for bis-nitrogenous
heme coordination, and it was thus concluded that the dioxy-
genase distal pocket contained a histidine. Perhaps most compel-
ling of all were studies with enzyme inhibitors,14 from which it
had been concluded that the reaction mechanism was critically
dependent on the presence of an active site base, presumed to
be histidine, which was responsible for abstraction of the
proton on the indole nitrogen in the ﬁrst step of the mechan-
ism (Scheme 2).
On the whole, proposals for the later stages of the mechanism
were less well formulated, mainly as a consequence of the diﬃ-
culty of isolating reaction intermediates. The reaction had been
proposed to occur through either Criegee15 or dioxetane16 path-
ways (Scheme 2).
It against is this background of information that the following
discussion is based.
’FIRST GLIMPSE OF THE DIOXYGENASE ACTIVE SITE:
THE CRYSTAL STRUCTURE OF HUMAN IDO
The dioxygenase enzymes have proved to be reluctant parti-
cipants in structural biology eﬀorts, but the emergence of expres-
sion systems for diﬀerent recombinant dioxygenases has meant
that suitably high concentrations of protein can now be gener-
ated in some cases. Table 1 gives a summary of bacterial
expression systems for various dioxygenases, and in a few cases,
structures have been published.1719 The ﬁrst of these was that of
recombinant human IDO,17 which was crystallized with the
inhibitor 4-phenylimidazole bound to the heme iron. The
structure revealed two distinct domains (large and small)
(Figure 1A) connected by a small loop of 17 residues.a
The active site (Figure 1B) conﬁrmed some of the earlier
predictions but also contained some unexpected surprises. The
structure revealed the presence of a proximal histidine, which was
in agreement with early predictions about the heme ligation from
spectroscopy5 and with more recent mutagenesis work in which
His346 had been predicted20 to be the ligand. Asp274 on the
proximal side had been suggested from mutagenesis20 either to
bind directly to the heme, which the structure shows not to be the
case, or to maintain a suitable conformation of the heme pocket.
This latter hypothesis proved to be correct because there is an
electrostatic interaction between this residue and Arg343 that is
presumably important for maintaining the overall structure
(Figure 1B).
Scheme 2. Previous Literature Proposals5,14,15 for the Reaction Mechanism for Heme Dioxygenasesa
aReaction of ferrous hemewithO2 andTrp leads to a ternary complex that reacts by base-catalysed abstraction to form a peroxyindole intermediate. This
species was proposed to decay by either Criegee (blue) or dioxetane (red) pathways.
Table 1. Summary of Expression Systems for a Number of
Dioxygenase Enzymes
enzyme species ref
indoleamine 2,3-dioxygenase human 12, 17, 54, 56, 57
mouse 57
Shewanella oneidensis 18
tryptophan 2,3-dioxygenase human 28, 29, 58
rat 5961
Xanthomonas campestris 18
Ralstonia metallidurans 19
mosquito 62, 63
scallop 64
Figure 1. (A) Overall structure of human IDO,17 showing the large
(red) and small (blue) domains, the loop region (yellow), the heme (in
green), the proximal histidine residue (His346, red), and the bound
inhibitor, 4-phenylimidazole (green). (B) Active site of human IDO17
with the heme colored red. There is one molecule of the inhibitor
4-phenylimidazole (green) bound to the heme iron in the structure and
two molecules of the crystallization buﬀer (CHES, not shown) in the
active site. Figures 1 and 2 were prepared using Pymol.66
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Overall, the IDO molecule contains a large number of hydro-
phobic Phe and Tyr aromatic residues (not shown), including
those in the distal heme pocket (Figure 1B). This was to be
expected to accommodate binding of the rather hydrophobic
tryptophan substrate. Most surprisingly, and in direct conﬂict
with literature proposals about the mechanism,5 there was no
histidine residue in the distal pocket.b At least for IDO, therefore,
the low-spin (presumed bis-nitrogenous5) species observed
spectroscopically12,13,21 cannot arise from coordination of a distal
histidine to the heme. Spectroscopic artifacts (often at cryogenic
temperatures) relating to heme coordination are well-known in
other catalytic heme enzymes, and the earlier interpretations for
TDO may well also have been complicated by the fact that the
heme groups of the tetramer have now been shown to be
inequivalent.22 In fact, the entire IDO active site is almost
completely devoid of polar residues: Ser167 is the only candidate
(Figure 1B), but this residue was later shown by mutagenesis23
not to be essential for O2 or substrate binding or turnover. This
absence of a distal histidine presented a further obvious diﬃculty:
because the reaction mechanism was presumed to involve base-
catalyzed abstraction of the indole proton (Schemes 2 and 3A),
the absence of the necessary base meant that this clearly now
needed reassessment. As an alternative, it was suggested17 that
abstraction of protons by the bound O2 was more likely [a
suggestion ﬁrst put forward by Terentis et al.13 (Scheme 3B)].
These suggestions are developed further below.
’SUBSTRATE BINDING INTERACTIONS: THE CRYSTAL
STRUCTURE OF BACTERIAL TDOS
The crystal structure of the bacterial X. campestris TDO to a
large extent conﬁrmed the generally hydrophobic nature of the
dioxygenase active site and revealed the high degree of structural
similarity between the TDO and IDO active sites (Figure 2A).
Structures for the R. metallidurans TDO19 and S. oneidensis
IDO18 enzymes have also been published and show similar
features in the active site (but substrate is not bound in these
structures).
The most signiﬁcant structural information was that for the
substrate-bound complex of the X. campestris enzyme (Figure 2B).
This revealed, for the ﬁrst time, the binding interactions holding
the substrate inside the pocket. Most provocatively, in this case
there is a distal histidine residue (His55) that overlays with the
equivalent (Ser167) residue in human IDO and forms hydrogen
bonds to the indole proton on N1! Although, in principle, this
seemed to imply that the base-catalyzed abstraction mechanism
may be possible (Scheme 2), site-directed mutagenesis data24 do
not support such a role because the X. campestrisH55A variant is
still catalytically active, albeit at a lower level (kcat that is∼10% of
the wild-type value).c In cases where His is present in the active
site [forX. campestris and R. metalliduransTDO, for instance, and
also assumed for hTDO (His76)], its full role is not yet
established, although it might be involved in holding the sub-
strate in a very precise orientation suitable for cleavage of the
C2C3 bond. This would ﬁt with spectroscopic work26 that
shows that substrate binding “locks” the bound O2 into a single
conformation (presumably suitably oriented for C2C3 bond
cleavage). In this context, we note that the closely related heme-
and O2-dependent PrnB enzyme binds its substrate diﬀerently:
27
in this case, the C2N1 bond of 7-chloro-L-Trp is cleaved (with-
out insertion of O2), and crystallography shows L-typtophan
binding in an orientation diﬀerent from that of X. campestris
TDO (Figure 3).
In X. campestris TDO, there are also ionic interactions with
Arg117, also presumably present in hIDO (to Arg231) and R.
metallidurans TDO (Arg134), and with the heme propionate
(Figure 2B). These ionic interactions would explain why sub-
strate binding is sensitive to substitutions at these charged
positions [e.g., D-Trp, tryptamine, indole priopionic acid, and
tryptophanol5,18,19,25,2831 (Scheme 4)] and in some cases
[e.g., tryptamine, indole propionic acid, and tryptophanol
(Scheme 4)] essentially eliminates activity altogether.28
’MECHANISM
As we highlighted in the introductory section, the briefest
glance at the literature would lead one to the conclusion that
there was little left to learn about the mechanism of tryptophan
oxidation. The mechanism presented in Scheme 2 was ﬁrst
suggested more than 40 years ago15 and has been widely
reproduced. It is a curiosity of the dioxygenase literature that
Figure 2. (A) Overlay of X. campestris TDO (green18) and hIDO
(white17), showing the active site residues (in parentheses for hIDO).
(B) Substrate binding site in X. campestrisTDO,18 showing the substrate
(orange) and the associated bonding interactions.
Figure 3. Overlay of the heme regions of X. campestris TDO (gray18)
and PrnB (pale blue27), showing the diﬀerent orientations of the
substrate (L-Trp for TDO and 7-Cl-Trp for PrnB, both colored gray,
with the Cl atom colored green). The heme groups are overlaid in red.
(B) Reaction catalyzed by PrnB (compare to Scheme 1).
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these proposals became deeply entrenched despite the fact that
there was no experimental evidence for either of them.
One feature of the proposed mechanism (Scheme 2) that
immediately stands out is that only a single initial reduction of the
heme is required for turnover and that there is no further change
in oxidation state of the heme iron during turnover.d If correct,
this quite obviously diﬀerentiates the heme dioxygenases from
other O2-dependent heme enzymes (e.g., P450s and NO
synthases) in which a second reduction of the iron and proton-
ation leads to rapid formation of an oxidized ferryl heme
(Compound I), which then needs further re-reduction from a
suitable reductase. This is discussed further below.
First Step: Base-Catalyzed Abstraction or Not? The first
step of the mechanism had been proposed as a base-catalyzed
abstraction of the indole proton. The suggestion was first put
forward by Hamilton15 and was based on the idea that only
substrates containing a proton on the indole nitrogen were active.
Others14 drew similar conclusions on the basis of the observation
that 1-methyltryptophan (Scheme 4) was an inhibitor of dioxy-
genase activity. Because base-catalyzed abstraction is not possible
for a 1-methylated substrate, the presence of an active site
histidine (as the base) was assumed (Scheme 3A). As we explain
above, the absence of an active site base in hIDO meant that this
mechanism needed revision, and the mechanism as shown in
Scheme 3B was proposed.13,17 In fact, there are chemical
difficulties with both mechanisms drawn in panels A and B of
Scheme 3, because the electrons in the NH (σ) bond are
perpendicular to the π-orbitals of the aromatic ring and so could
not be used to directly activate the aromatic ring for electrophilic
attack on oxygen.
Computational work from Chung and co-workers32 raised the
ﬁrst questions about the likelihood of a base-catalyzed abstrac-
tion mechanism, and electrophilic addition was suggested as one
of a number of alternative mechanisms. To date, the main
experimental evidence comes from mass spectrometry work33
that has shown that 1-Me-Trp is actually a slow substrate for
several dioxygenase enzymes, thus ruling out both mechanisms
in panels A and B of Scheme 3, because neither is possible with
the methyl-substituted indole. This would be consistent with
mutagenesis data that show that when a distal histidine is present
its removal does not shut down activity completely.24 Spectro-
scopic work using 1H ENDOR26 has since shown that the indole
NH group is not hydrogen bonded to the bound O2 in the
ternary complex, further arguing against the mechanisms shown
in panels A and B of Scheme 3. Others34 have drawn similar
conclusions from computational work, and there now seems to
be a consensus that base-catalyzed abstraction does not occur.
In fact, the chemistry of indoles has a long and well-
documented history, and they do not react by base-catalyzed
abstraction.35 This then raises the question of what happens
instead. There are two alternative mechanisms, both of which
would accommodate the reactivity of 1-Me-Trp33 and would
avoid the conceptual diﬃculty of needing to deprotonate an
indole NH group that has a theoretical pKa that is very
high (pKa ≈ 1736). In the ﬁrst case, the lone pair on
nitrogen initiates electrophilic addition to the bound O2 ligand
33
(Scheme 3C). This route was identiﬁed computationally,32
and electrophilic addition would be consistent with the known
chemistry of indoles; however, O2 is typically not a very good
electrophile, and certainly in the case of the globins,
the ferrousoxy bond is best formulated as an FeIIIO2
species.37 An alternative is radical addition (P. Ortiz de
Montellano, personal communication) (Scheme 3D), again
identiﬁed as a contender by computational work.33,34,38 This
too would allow for reactivity of 1-Me-Trp and is appealing in
Scheme 3. Variously Proposed Reaction Mechanisms for Heme Dioxygenasesa
a (A) The base-catalysed abstraction mechanism.14,15 (B) An alternative to the base-catalysed mechanism, using abstraction of protons by the bound
O2.
13,17 (C) Electrophilic addition.32,33,42 (D) Radical addition.32,34,38,42 The majority opinion from crystallography,17 mass spectrometry,23
mutagenesis,24 and computational work32 concludes that mechanisms A and B are unlikely. It is not yet known whether addition at C3 or C2 is
most likely; both have been suggested.3234,38,42,65.
Scheme 4. Structures of the Various Tryptophan Analogues
Mentioned in This Work
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the sense that it would require an FeIIIO2 formulation for
the ferrousoxy heme. It is not yet clear which mechanism, if
either, is used.
Second Step: Criegee orDioxetane?.The Criegee mechan-
ism is well-known in the non-heme iron literature (see, for
example, ref 39) but there is no experimental evidence of
either a Criegee15 or a dioxetane16 mechanism in the heme
dioxygenases. As Scheme 2 makes clear, neither mechanism
requires a formal change in oxidation state during turnover
(which is unusual for heme-mediated catalysis). However,
there is more than one report implicating formation of a
ferryl heme species during dioxygenase turnover. The first
came from Yeh and co-workers,38 who used resonance Raman
methods to observe a stretching frequency characteristic of
ferryl heme (νFedO), assigned as Compound II, during turn-
over in hIDO (but, curiously, not in hTDO). A similar
stretching frequency has been independently observed in
IDO.40,41 This has led to the suggestion38 that simultaneous
incorporation of both atoms of O2, as dictated by Scheme 2,
does not occur but that instead sequential (stepwise) inser-
tion of oxygen into the substrate and accompanying oxidation
to ferryl heme is the preferred route, as depicted in Scheme 5A.
Recent computational work42 supports epoxide formation
as the first oxygenation step (although pathways involving
highly valent iron ferryl heme had also been suggested by
previous work32).
If correct, there are features of the mechanism shown in
Scheme 5A that align with known behavior in related enzymes.
Epoxide formation is, of course, well established in the P450
literature, but through direct reaction of a Compound I inter-
mediate with the substrate. We note also that isomerization of
endoperoxides by the heme enzymes prostacyclin synthase and
thromboxane synthase has also been suggested to occur by
homolytic cleavage of the bound endoperoxide OO bond
and formation of ferryl heme.43 There is also an analogy with
the non-heme iron enzymes (e.g., tyrosine hydroxylase44) in
which formation of an FeIVdO species, from ferrous iron andO2,
also occurs.
There is still no experimental evidence relating to the ﬁnal part
of the mechanism, conversion of the proposed intermediates into
NFK. Computational work has, so far, provided the only infor-
mation,32,42 and the most recent conclusions42 do not support
either Criegee or dioxetane mechanisms. From a chemical pers-
pective, we note that the epoxide intermediate would be expected
to undergo facile C2O bond cleavage (because of the adjacent
nitrogen lone pair), which may mean that the ﬁrst step in the
C2C3 bond cleavage process involves ring opening as we show
in Scheme 5A. Indeed, there is precedent for such epoxide ring
opening from studies on the chemical epoxidation of tryptophan
by peracids.45 This would agree with recent computational
analyses42 that also support ring opening of the proposed epoxide
intermediate, possibly assisted by the protonated amine group of
the substrate (which, from spectroscopic data,26 is thought to be
within hydrogen bonding distance of the bound distal O2)
(Scheme 5B). Subsequent steps in the detailed mechanism of
conversion of the epoxide to NFK have been proposed42
(Scheme 5B), but these ideas have yet to be veriﬁed experi-
mentally. There are interesting parallels to be drawn with other
systems, most notably in the PrnB enzyme mentioned above27,46
and in indole alkaloid biosynthesis,47 because in both cases the
involvement of the substrate amine group in the reaction
mechanism is likewise implicated. These systems may provide
important clues as the details of the dioxygenase mechanism
are unravelled.
’MECHANISTIC SIMILARITIES AND DIFFERENCES
WITH OTHER HEME ENZYMES
Oxygen activation by heme enzymes can be achieved in
various ways but often occurs via formation of highly oxidized
iron intermediates (Compound I and Compound II). The most
well-known examples are in the cytochrome P450s, nitric oxide
synthases, cytochrome c oxidases, and heme peroxidases.7,46,4851
Typically, the reductive activation of O2 begins from the ferrous
oxy intermediate and is followed by a further reduction and a
protonation, to form a ferrichydroperoxy species (which is also
Scheme 5. Alternative Mechanistic Proposala
a (A) Radical addition (instead of base-catalysed abstraction) leading to species X is followed by formation of a ferryl heme species (Compound II) and a
proposed epoxide species.38 Formation of an epoxide has also been suggested by computational work42 (in fact, it was considered in an earlier study, but
initially considered energetically unfavorable in the gas phase32). Electrophilic addition (Scheme 3C) could also involve epoxide formation through a
similar (two-electron) mechanism. Possible ring opening of the epoxide is also indicated. (B) Proposed42 mechanism for subsequent formation of NFK,
starting from the same species X as in panel A, and also involving initial ring opening.
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used in the heme oxygenase reaction mechanism52,53). Rapid
heterolytic cleavage of the OO bond leads to the “activating”
Compound I species, which is also accessed via a direct reaction
with hydrogen peroxide (e.g., in the peroxidase enzymes)
(Scheme 6). This cycling through a high-valent Compound I
species during turnover of course demands continuous reduc-
tion of the heme group, and thus the need for an appropriate
reductase partner. The physiological partner reductase for the
dioxygenases is not known with certainty, but for IDO, there is
evidence of it being a cytochrome b5.
54,55 Regardless of
the source of the electrons, the evidence so far is that the
dioxygenases require only a single, initiating reduction of ferric
heme; further reduction and protonation of the ferrousoxy
heme would presumably not be a productive pathway for a
dioxygenase, because it leads to the formation of Compound I.
In fact, there is evidence from ENDOR work26 that substrate
binding shields the ferrousoxy complex from protonation in
dioxygenases, which may be one of the strategies that the
dioxygenases employ to control the reactivity of the fer-
rousoxy species and unproductive mechanistic pathways.
’FUTURE DIRECTIONS
In this review, we have focused on structural and mechan-
istic information. We know much more about what makes a
heme dioxygenase than we did even ﬁve years ago. Literature
mechanisms have slowly unravelled as new information has
emerged, and new proposals are being put forward that have
themselves yet to stand the test of time. Many questions and
challenges remain though. As we noted at the beginning, the
absence of any information about the reaction intermediates
has been a long-standing diﬃculty that has hindered progress
and the precise mechanism has yet to be established. Further
work on identiﬁcation of these reaction intermediates, both for
the transient heme species and indeed for the substrate as it
turns over to form NFK, will surely be essential in this overall
quest and will require contributions from spectroscopists,
enzymologists, structural biologists, and theoreticians alike.
Together, this should provide the necessary fuel for further
informative debate.
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